COA purity vs. content assay: what each one tells you

What the two numbers measure

A peptide COA can show a high HPLC purity value and still leave a separate question unanswered: how many milligrams of target peptide are present in the vial. HPLC purity is an area-percent comparison between chromatographic peaks. A content assay is an absolute amount measurement. Both support in-vitro reference standard work, but they answer different bench questions during receiving, method setup, and quantitative review. [1]

HPLC area-percent is a ratio, not a mass assay

HPLC purity on a peptide COA usually means area-percent purity from a reversed-phase HPLC chromatogram. The common readout is collected near 220 nm, where the peptide backbone absorbs strongly. The integration software measures the area under the main peak, then divides it by the total area under all integrated peaks above the reporting threshold. If the main peak contributes 99.5 % of the integrated UV area, the COA reports HPLC purity of 99.5 %. That number is a chromatographic ratio. It is not the same as grams of peptide per gram of powder. [2]

The distinction matters because UV area is response-weighted. Two impurities at equal mass can produce different peak areas if their chromophores, retention times, or ion-pairing behaviour differ. A truncated sequence containing aromatic residues can look larger at 220 nm than a non-absorbing salt at the same mass. A counter-ion, residual water, or inorganic residue can add mass to the vial without creating a matching UV peak. That is why HPLC purity can remain strong even when the lyophilizate contains material that does not register as a peptide-related peak. [3]

A chromatogram is still central to routine characterisation. It tells the bench whether the peptide-related profile is dominated by one component, whether late-eluting hydrophobic impurities are present, and whether the method resolved shoulder peaks around the main component. For products such as <a href="/product/cp-001">Semaglutide CP-001</a> and <a href="/product/cp-002">Tirzepatide CP-002</a>, the HPLC method, wavelength, gradient, column chemistry, and integration threshold should be read together. The article on <a href="/research-guide/reading-an-hplc-chromatogram">reading an HPLC chromatogram</a> is the right companion when the COA includes the trace. [4]

Content assay answers the vial-mass question

A content assay asks a different question: how much target peptide is present in the container. The answer is usually reported as milligrams per vial, percent of label claim, or percent content after correction for salts and water. Two common approaches are quantitative amino-acid analysis and reference-standard-calibrated HPLC with an external standard. In amino-acid analysis, the peptide is hydrolysed, often under acidic conditions for about 20 to 24 hours, and the released amino acids are quantified against calibrated references. The result is reconstructed into peptide amount using the known sequence. [5]

Reference-standard-calibrated HPLC works differently. The lab prepares a calibration curve from a qualified reference standard at known concentrations, injects the sample under the same method, and calculates the amount from peak response. This can be useful when the target peptide is stable under the sample-preparation conditions and the detector response is linear across the working range. A five-point calibration curve with replicate injections gives stronger evidence than a single-point estimate, especially when the target concentration is near the edge of the validated range. [6]

Content assay reporting is more demanding than area-percent purity. It depends on weighing accuracy, dilution factors, moisture correction, counter-ion assignment, reference material traceability, and method recovery. For comparator quantification or binding experiments that depend on stoichiometry, that added work is justified. For a lyophilized research vial, the content assay tells the scientist whether the nominal fill and the actual target-peptide amount are aligned. HPLC purity alone cannot answer that question, even when the peak profile is clean. [7]

Why the two values can disagree

The simplest disagreement comes from water. Lyophilized peptide cakes are dry solids, but they are not water-free. <a href="/research-guide/karl-fischer-water-content">Karl Fischer water content</a> of 2-6 % is common for a well-controlled lyophilizate, and higher values can appear when storage, packaging, or the drying cycle is weak. HPLC area-percent purity does not subtract that water mass. If a vial reports 99.5 % HPLC purity and 6.0 % water content, an uncorrected view overstates the amount of target peptide in the solid. A rough mass correction gives 99.5 % multiplied by 94.0 %, or about 93.5 % of nominal mass as target peptide before other corrections. [8]

Counter-ions create a second difference. Many synthetic peptides are isolated as acetate or trifluoroacetate salts after cleavage and purification. The counter-ion can be analytically important, but it is not the peptide sequence itself. A peptide reported as 99.0 % by HPLC may still carry a meaningful counter-ion fraction by mass. If a stoichiometric calculation assumes the entire vial mass is neutral peptide, the final molar concentration will be too high. The gap grows with smaller peptides because the counter-ion represents a larger share of total molecular mass.

Non-absorbing or weakly absorbing impurities create a third gap. Residual inorganic salts, buffer components, and trace process residues can add mass with little signal at 220 nm. Conversely, a UV-active peptide impurity can reduce HPLC area-percent purity even when absolute target content remains close to expectation. This is why a release-quality COA often reports HPLC purity, mass spectrometry identity, water by Karl Fischer, residual solvents, and sometimes content assay. Each line constrains a different failure mode. For <a href="/product/cp-003">Retatrutide CP-003</a>, a clean mass-spectrum identity line and a strong HPLC trace still do not replace water or content data when the experiment depends on exact molarity. For most peptides in our catalog with <a href="/research-guide/karl-fischer-water-content">Karl Fischer</a> values in the 3-5% range and stated acetate or TFA counter-ions, the effective mass delivered sits within 92-97% of nominal, which is sufficient for most in-vitro characterisation work but warrants a dedicated content assay for binding-affinity calibration. On Canada Peptides COAs, content assay is run on request for lots earmarked for stoichiometric quantification — see the <a href="/wholesale">wholesale enquiry</a> for the workflow.

Which number matters for the bench decision

For routine in-vitro characterisation, HPLC purity is often the first number to read. It shows whether the vial is dominated by the intended peptide-related peak and whether the impurity profile is narrow enough for screening, method development, or reference comparison. In a sourcing review, a COA with HPLC purity >= 98.0 %, matching mass spectrometry identity, and clear chromatographic conditions is easier to evaluate than a document that lists a purity number without method detail. The method line matters because a shallow 30-minute gradient can resolve impurities that a short 8-minute screening method may merge into the main peak.

For stoichiometric work, content assay becomes more important. Binding affinity measurements, calibration of a comparator curve, isotope-ratio work, and quantitative recovery studies all require the scientist to know how many moles of target peptide enter the vessel. A 5 % overestimate in stock concentration can shift an apparent affinity constant or calibration slope. When the COA lacks a content assay, the next best review is to cross-check HPLC purity against Karl Fischer water content, counter-ion reporting, and the supplier's stated fill tolerance.

The practical rule is simple: use HPLC purity to assess the peptide-related impurity profile; use content assay to assess absolute target amount. When both are present, read them together. A COA showing 99.4 % HPLC purity, 3.0 % water by Karl Fischer, and 98.0 % content gives a coherent picture. A COA showing 99.7 % HPLC purity and no water, no counter-ion, no content, and no chromatogram gives less evidence than the headline suggests. The stronger document lets the scientist reconstruct the measurement chain rather than trust one attractive number. It also lets a second lab repeat the concentration logic without asking for private batch notes.

How to cross-check a COA without content assay

Many research lots do not include a formal content assay, so the reviewer has to build a mass-balance picture from adjacent COA lines. Start with HPLC purity, then read Karl Fischer water, residual solvents, counter-ion form, and mass spectrometry identity. If HPLC purity is 99.2 %, water is 4.5 %, and residual solvents are below the reporting threshold, the main uncorrected mass item is water plus any counter-ion fraction. That does not produce a perfect content number, but it prevents the common error of reading the area-percent purity as a full mass assay.

Counter-ion reporting is the most frequent missing line. If the supplier states acetate or TFA salt form, the molecular mass used for stock calculations should match that form when exact molarity matters. If the salt form is not stated, ask for the counter-ion result or use the method objective to decide whether nominal fill is sufficient. A qualitative HPLC comparison may not need full correction. A calibration curve for a comparator set probably does. The strongest habit is to write the assumption in the lab notebook: nominal fill used, water not corrected; or content corrected using COA water and stated salt form. That note prevents two analysts from preparing different stocks from the same vial. It also helps explain why a later concentration audit may differ from the original bench sheet by 3-7 %.

Summary

HPLC purity and content assay are complementary COA fields, not competing labels. One describes the chromatographic profile. The other estimates the absolute amount of target peptide in the vial. A release review should not force one number to answer both questions or hide the calculation basis. The useful COA makes both assumptions visible.

• HPLC area-percent at 220 nm reports a UV peak-area ratio, not mass content.

• Content assay estimates milligrams or percent of target peptide using quantitative amino-acid analysis or calibrated HPLC.

• Water, counter-ion mass, and non-absorbing residues can make a 99.5 % HPLC vial behave like about 93.5 % target mass when water is 6.0 %.

• For routine in-vitro reference standard checks, start with HPLC purity; for stoichiometric calculations, look for content assay and Karl Fischer data.

FAQ

Is HPLC purity the same as peptide content?

No. HPLC purity is usually a peak-area percentage from a chromatogram. Peptide content is an absolute amount estimate for the target sequence in the vial.

Why can a high-purity peptide still have less target mass than expected?

Water, counter-ions, and non-absorbing residues add mass without necessarily appearing as peptide-related UV peaks. Karl Fischer water data helps explain part of that gap.

Which method is better for molarity calculations?

A content assay is better for molarity because it estimates the actual target amount. HPLC purity is still useful, but it does not provide the full mass correction.

What should a strong COA include besides HPLC purity?

Look for mass spectrometry identity, Karl Fischer water content, residual-solvent reporting, counter-ion information where relevant, and clear method conditions.

Can calibrated HPLC be used as a content assay?

Yes, when the method is validated for linear response, sample recovery, and comparison against a qualified external reference standard.

Frequently asked questions

References

1. Aguilar M. (n.d.). HPLC of Peptides and Proteins: Basic Theory and Methodology. HPLC of Peptides and Proteins. · DOI
2. Aguilar M. (n.d.). Reversed-Phase High-Performance Liquid Chromatography. HPLC of Peptides and Proteins. · DOI
3. Rauh M. (2012). LC–MS/MS for protein and peptide quantification in clinical chemistry. Journal of Chromatography B. · DOI
4. Schoeffski K., Hoffmann H. (2010). Karl Fischer Titration: Determination of Water Content in Pharmaceuticals. Pharmaceutical Sciences Encyclopedia. · DOI
5. Connelly J. (2017). ICH Q3C Impurities. ICH Quality Guidelines. · DOI
6. Roux S., Zékri E., Rousseau B. et al. (2007). Elimination and exchange of trifluoroacetate counter‐ion from cationic peptides: a critical evaluation of different approaches. Journal of Peptide Science. · DOI
7. Sikora K., Neubauer D., Jaśkiewicz M. et al. (2017). Citropin 1.1 Trifluoroacetate to Chloride Counter-Ion Exchange in HCl-Saturated Organic Solutions: An Alternative Approach. International Journal of Peptide Research and Therapeutics. · DOI
8. Whitelegge J. (n.d.). HPLC and Mass Spectrometry of Intrinsic Membrane Proteins. HPLC of Peptides and Proteins. · DOI